NINA Medical

Non-invasive Solution for Men with an Enlarged Prostate (BPH)

Health Tech & Life Sciences
Active
Seed Netanya, Israel Founded 2019
Last updated 2026-06-18
Total raised
$3.7M
Last: 2025-09
Stage
Seed
Founded
2019
Headcount
10
HQ
Netanya, Israel
Sector
Health Tech & Life Sciences

About

NINA Medical pioneers a non-invasive treatment for Benign Prostatic Hyperplasia (BPH), a common, non-cancerous enlargement of the prostate that significantly impacts the quality of life and increases the risk of complications in aging men. NINA Medical is at the forefront of this field, offering the world's first non-invasive ultrasound-based treatment, which ensures unparalleled comfort and precision. Founded by experts in medical physics, the company's core technology enables a truly non-invasive (distinct from minimally invasive) approach to the prostate, facilitating both imaging and treatment of BPH within a urologist's office. This groundbreaking solution promotes early intervention without the need for invasive procedures, ensuring men receive treatment without the discomfort associated with traditional methods. NINA Medical has demonstrated technological readiness through animal trials and a preliminary clinical study involving 20 patients, and is now preparing for its first-in-human clinical trial. The company has consistently received support from the Israel Innovation Authority (2019, 2021, 2024) and is backed by private investors. The First-in-Human clinical study is ongoing in an Israeli hospital.

Funding history · 8 rounds · $3.7M total

2025-09
2025-02
$800K
2024-04
Grant $500K
2024-04
$388K
2023-01
$180K
2021-06
2019-06
Grant $723K
2019-06
$128K

Q&A

What is NINA Medical's primary focus?
NINA Medical is developing a non-invasive ultrasound-based treatment for Benign Prostatic Hyperplasia (BPH), a common prostate enlargement in aging men.
When was NINA Medical founded?
NINA Medical was founded in January 2019.
What is the current status of NINA Medical's clinical trials?
NINA Medical has completed animal trials and a preliminary clinical study with 20 patients and is currently conducting its first-in-human clinical study in an Israeli hospital.
How much funding has NINA Medical raised in total?
NINA Medical has raised a total of $3,667,875 in funding.
Which investors participated in NINA Medical's September 2025 funding round?
In September 2025, NINA Medical received funding from Rafael Holdings.
What is NINA Medical's employee count?
NINA Medical has 1-10 employees.
Who are the co-founders of NINA Medical?
The co-founders of NINA Medical are Shmuel Ben-Ezra (CEO), Yoni Hertzberg (CTO), and Alex Volovick (Clinical Applications Manager).
What is NINA Medical's current funding stage?
NINA Medical is currently in the Seed funding stage.

Team · 3

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & CTO
LinkedIn ↗
Founder · Clinical Appplications Manager
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical DevicesMedical Treatment & Therapeutics
Technologies
Simulation & ImagingUltrasound
Target customers
Healthcare & Life SciencesHealthcareProvidersMedical Devices IndustryMedical Equipment
Business model
B2B

Highlights

1 PatentsVerified

Tags

medical-technologiesnon-invasiveultrasounddigital-healthcarereal-timediagnosticsmedical-devicessurgeonsdegenerative-diseasesurologyimaging
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)